Found vs Willow: Biology-First Plans vs Structured Tracking
Found vs Willow compares two telehealth weight management approaches: Found centers on a biology-first, personalized medically supervised program with affordable monthly plans, while Willow emphasizes an oral GLP-1 program with progress tracking and follow-up support. Early verdict: choose Found for insurance-friendly, biology-based plans starting as low as $39; choose Willow if you prioritize structured progress tracking and follow-up consultations.
Explore Found plans starting as low as $39
How they differ: program focus and care model
Found and Willow take different core approaches. Found describes a biology-first approach that builds personalized programs around hormones, blood sugar regulation, sleep, and behavioral factors. Willow positions its offering as a structured weight management journey focused on turning medication effectiveness into sustainable outcomes through progress tracking and follow-up support. Both use telehealth and licensed clinicians to determine medical appropriateness.
See Willow’s oral GLP-1 program and tracking tools
Distinctive differences organized by evidence
1. Personalized biology-first planning vs structured follow-up
Found emphasizes a personalized medically supervised program tailored to a patient’s metabolic biology, including hormones and lifestyle. Willow emphasizes structured digital follow-up, progress tracking, and follow-up consultations to support long-term results beyond medication alone.
2. Pricing and insurance signals
Found advertises getting started for as low as $39 and states most insurance is now accepted, with details noting insurance coverage, pricing, and terms vary. Willow’s captured evidence lists an entry price of 299 and indicates higher monthly entry pricing for some plans. Found also highlights programs and options tied to Medicare and handling insurance paperwork; actual eligibility and coverage vary and are subject to program criteria.
Check Found’s pricing and insurance options
3. Medication types and regulatory notes
Found lists tirzepatide and semaglutide, including compounded GLP-1s, and explicitly notes that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality. Willow’s evidence emphasizes oral GLP-1 treatment and also notes branded and compounded products are not interchangeable and that medication-specific approval status must be confirmed. Both say treatment is available only when a licensed clinician determines it is medically appropriate.
4. Program features and target users
Found highlights targeting hormones, metabolism, and lifestyle with a holistic whole-body approach and says it is best for people who want weight loss built around their biology. Willow highlights a licensed telehealth team, progress tracking tools, and follow-up consultations and says it is best for users who want structured digital follow-up.
Quick comparison table
| Criteria | Found | Willow |
|---|---|---|
| Program focus | Biology-first personalized medically supervised program | Structured oral GLP-1 journey with progress tracking |
| Starting price | Starting at $39 | 299 |
| Insurance | Most insurance now accepted; coverage varies | Not verified on captured page |
| Medications noted | Tirzepatide, semaglutide, compounded options listed | Oral GLP-1; branded and compounded status must be confirmed |
| Follow-up and tracking | Personalized clinical program with holistic focus | Progress tracking tools and follow-up consultations |
| Regulatory note | Compounded medications not FDA-approved or reviewed | Medication-specific approval status must be confirmed |
Clinical eligibility, safety, and limits
Both providers require clinician review and clinical eligibility for prescriptions. Found explicitly warns that certain medications are FDA-approved for conditions other than weight and that compounded GLP-1s are not FDA-approved, not evaluated for safety or efficacy, and not available in all states. Willow’s captured evidence notes that treatment is available only when a licensed clinician determines it is medically appropriate and that approval status must be confirmed.
Learn more about Willow’s clinician-reviewed program
Choosing between Found and Willow
Choose Found if you want a biology-first, personalized medically supervised program with affordable monthly plans and explicit insurance support signals, including options starting as low as $39 and mention of handling insurance paperwork and Medicare-related programs. Choose Willow if you prioritize a telehealth-first oral GLP-1 program with progress tracking tools, structured follow-up consultations, and a focus on converting medication benefit into long-term behavior change.
Start Found’s biology-based program
Primary keyword: Found vs Willow